Patent ID: 6432679
Filing Date: 2002-08-13
Classification: A61K,A61P,C07K,C12N

Abstract:
A method of treating a patient comprising: administering a composition comprising:at least one Epstein-Barr virus (EBV) Gp350/220 sequence that binds to a CR2 receptor (CR2) covalently conjugated to at least one protein, peptide, polypeptide, or polysaccharide comprising an antigenic epitope other than an epitope of EBV Gp350/220; such that said EBV Gp350/220 sequence and said protein, peptide, polypeptide, or polysaccharide are on the same molecule; wherein the composition promotes a humoral immune response with respect to said antigenic epitope other than an epitope of EBV Gp350/220.